Skip to main content
logo
Pennon Group Plc (LON:PNN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
496.60
-2.80 (-0.56%)
Aug 8, 2025, 4:35 PM BST

Revance Therapeutics Revenue

In the fiscal year ending March 31, 2025, Pennon Group had annual revenue of 1.05B GBP with 15.44% growth. Pennon Group had revenue of 519.60M in the half year ending March 31, 2025, with 40.17% growth.

Revenue
1.05B
Revenue Growth
+15.44%
P/S Ratio
2.24
Revenue / Employee
267.79K
Employees
3,909
Market Cap
2.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251.05B140.00M15.44%
Mar 31, 2024906.80M110.60M13.89%
Mar 31, 2023796.20M4.90M0.62%
Mar 31, 2022791.30M168.20M26.99%
Mar 31, 2021623.10M-12.60M-1.98%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
National Grid18.38B
SSE plc10.13B
Severn Trent2.43B
Centrica19.50B
United Utilities Group2.15B
Greencoat UK Wind-11.51M
Drax Group5.65B
Telecom Plus1.84B
Revenue Rankings

Pennon Group News

More News